Yulia Wardhani

Yulia Wardhani

Auto-generated profile, based on publicly available information

Yulia Wardhani

Nephrology and Hypertension, Department of Internal Medicine, Faculty of Public Health Medicine and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in Journal of Nephropharmacology
Verified
Journal Article
Closed access
SRSiti Nur Rohmah
Siti Nur Rohmah
MPMetalia Puspitasari
Metalia Puspitasari
YWYulia Wardhani
Yulia Wardhani
NANur Rahmi Ananda
Nur Rahmi Ananda
AKAlfreda Amelia Khotijah
Alfreda Amelia Khotijah
Introduction: One of the most serious bacterial infections following kidney transplantation is tuberculosis (TB). Immunosuppressive medications and anti-tuberculosis therapy (ATT) frequently interact with one another and cause adverse effects. This case series focuses on kidney transplant patients who have active TB, with varying clinical manifestations and outcomes. Case-1: A 42-year-old man with end-stage renal disease (ESRD) underwent a kidney transplant from an unrelated living donor. He was diagnosed with disseminated TB post-transplant. Third-month post-ATT, serum creatinine was increased. His kidney allograft failed and required hemodialysis, but he died. Case-2: A 31-year-old female with ESRD underwent a kidney transplant from an unrelated living donor. She was diagnosed with pulmonary TB post-transplant. Third-month post-ATT, her tacrolimus decreased significantly; however, her kidney allograft remained stable and still alive. Case-3: A 29-year-old male with ESRD underwent a kidney transplant from an unrelated living donor. He was diagnosed with pulmonary TB post-transplant. Third-month post-ATT, tacrolimus levels decreased significantly but her kidney allograft remained stable. Case-4: A 60-year-old man with ESRD underwent a kidney transplant from an unrelated living donor. He was diagnosed with Disseminated TB post-transplant. Third-month post-ATT, tacrolimus levels decreased significantly’ since, her kidney allograft remained stable. Conclusion: After kidney transplantation, TB might be difficult to diagnose and treat because of its unusual symptoms and varying outcomes. During the first three months of ATT, there may be significant interactions between tacrolimus and ATT. Therefore, frequent and careful monitoring along with medication modifications are required. Tuberculosis prophylaxis is essential for recipients after transplantation, particularly in endemic countries.

24 December 2024 in Indonesian Journal of Kidney and Hypertension
Verified
Journal Article
Open access
PDF file
RDRatna Damayanti
Ratna Damayanti
IKIri Kuswadi
Iri Kuswadi
RPRaden Heru Prasanto
Raden Heru Prasanto
MPMetalia Puspitasari
Metalia Puspitasari
YWYulia Wardhani
Yulia Wardhani
DKDanny Pratama Kuswadi
Danny Pratama Kuswadi
Background: Studies indicate that large fluctuations in pulse pressure during hemodialysis are associated with cardiovascular events, cardiovascular mortality, and all-cause mortality. Objective: We investigated the determinants of detrimental changes in pulse pressure (ΔPP) during hemodialysis. Methods: This prospective, observational cohort study was conducted from 1 to 30 April 2023 at Dr. Sardjito Hospital Yogyakarta, involving maintenance hemodialysis patients for ≥ 6 months. Patients were categorized into group 1 (detrimental ΔPP, ΔPP >5 mmHg or <−25 mmHg) and group 2 (stable ΔPP, −25 to 5 mmHg). Mann-Whitney, independent-t, chi-square, Fisher exact tests, and logistic regression were applied to evaluate associations between ΔPP groups and clinical variables. Results: This study involved 136 patients, 75 males (55.1%) with a mean age of 52 (18-87). The most common comorbid was hypertension, present in 85 patients (62.5%). The mean hemodialysis vintage of patients was 47.2 (6.5-330.7) months. We found significant difference between group in post-dialysis systolic blood pressure (SBP) (p=0.003), pre-dialysis diastolic blood pressure (DBP) (p=0.015), post-dialysis DBP (p=0.007), ultrafiltration (p=0.041), pre-dialysis mean-arterial-pressure (MAP) (p=0.013), post-dialysis MAP (p=0.002), and alpha-blocker treatment (p=0.037). Multivariate logistic regression analysis shows a significant association between groups of ΔPP with pre-dialysis DBP (p=0.035; OR=1.153; OR=Exp(10xℬ) =4.137) and post-dialysis SBP (p=0.007; OR=1.052; OR=Exp(10xℬ) =1.6487). Conclusion: Our study demonstrates that group 1, with detrimental changes in pulse pressure during hemodialysis, was found to have higher post-dialysis DBP, pre-dialysis DBP, post-dialysis SBP, pre-dialysis MAP, post-dialysis MAP, alpha-blocker treatment, and ultrafiltration, with significant association with post-dialysis SBP and pre-dialysis DBP.

6 November 2026 in Toxics
Verified
Journal Article
Open access
PDF file
MPMetalia Puspitasari
Metalia Puspitasari
IKIri Kuswadi
Iri Kuswadi
YWYulia Wardhani
Yulia Wardhani
SRSiti Nur Rohmah
Siti Nur Rohmah
DKDanny Pratama Kuswadi
Danny Pratama Kuswadi
Fahrul NurkolisFahrul Nurkolis
Fahrul Nurkolis
Foodborne mycotoxins are widespread environmental exposures, but their contribution to human kidney disease remains uncertain. This critical narrative review distinguishes food contamination, human internal exposure, experimental nephrotoxicity, and human renal outcomes and proposes an evidence-atlas framework that does not equate geographic overlap with causation. Quantitative examples illustrate the differences between evidence domains: in one Kenyan survey of 200 milled-rice samples, citrinin (CIT) and ochratoxin A (OTA) were detected in 55.5% and 30%, respectively, with reported ranges of 0–9 and 0–110 µg/kg across all samples. Human biomonitoring studies report frequent internal exposure, but exposure detection alone does not establish renal injury. Human renal studies are heterogeneous: one Taiwanese analysis reported an association between 24-h OTA excretion and proteinuria (N = 85; r = 0.303; p = 0.006), whereas a Polish comparison found no significant difference in mean serum OTA between 88 dialysis patients and 16 controls (0.75 versus 0.70 ng/mL). Experimental studies support toxin-specific mechanisms involving impaired antioxidant defense, mitochondrial disturbance, lipid-peroxide injury, and endoplasmic-reticulum stress, but tested doses and durations often differ from usual dietary exposure. Reverse causation, altered renal elimination, co-exposures, assay specificity, and inconsistent endpoints limit causal inference. The proposed atlas separates food-occurrence, biomonitoring, and renal-outcome evidence, while evaluating experimental mechanisms independently. Prospective studies integrating dietary assessment, repeated biomonitoring, and renal outcomes are needed to test temporality and dose–response outcome.